NF-κB as a therapeutic target in chronic inflammation: recent advances
- 1 November 2000
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 6 (11) , 441-448
- https://doi.org/10.1016/s1357-4310(00)01814-1
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Nuclear Factor κB Activity Is Essential for Matrix Metalloproteinase-1 and -3 Upregulation in Rabbit Dermal FibroblastsBiochemical and Biophysical Research Communications, 1999
- Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit PhosphorylationScience, 1999
- Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κBFEBS Letters, 1998
- NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.Journal of Clinical Investigation, 1998
- The many roles of CD40 in cell-mediated inflammatory responsesImmunology Today, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Inhibition of the DNA‐binding activity of NF‐κB by gold compounds in vitroFEBS Letters, 1995